Meditation and neurodegenerative diseases

被引：32
作者：
Newberg, Andrew B. [1 ]
Serruya, Mijail [1 ]
Wintering, Nancy [1 ]
Moss, Aleeze Sattar [1 ]
Reibel, Diane [1 ]
Monti, Daniel A. [1 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA
来源：
ADVANCES IN MEDITATION RESEARCH: NEUROSCIENCE AND CLINICAL APPLICATIONS | 2014年 / 1307卷
关键词：
meditation; neurodegenerative disease; cognition; memory; mindfulness; CEREBRAL-BLOOD-FLOW; ADRDA WORK GROUP; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; FRONTAL-CORTEX; MINDFULNESS; ATTENTION; SYSTEM; ACTIVATION;
D O I：
10.1111/nyas.12187
中图分类号：
R [医药、卫生];
学科分类号：
10 ;
摘要：
Neurodegenerative diseases pose a significant problem for the healthcare system, doctors, and patients. With an aging population, more and more individuals are developing neurodegenerative diseases and there are few treatment options at the present time. Meditation techniques present an interesting potential adjuvant treatment for patients with neurodegenerative diseases and have the advantage of being inexpensive, and easy to teach and perform. There is increasing research evidence to support the application of meditation techniques to help improve cognition and memory in patients with neurodegenerative diseases. This review discusses the current data on meditation, memory, and attention, and the potential applications of meditation techniques in patients with neurodegenerative diseases.
引用
收藏
页码：112 / 123
页数：12
相关论文
共 50 条
  • [31] Polygenic risk and pleiotropy in neurodegenerative diseases
    Bellou, Eftychia
    Stevenson-Hoare, Joshua
    Escott-Price, Valentina
    NEUROBIOLOGY OF DISEASE, 2020, 142
  • [32] Cerebral vasomotor reactivity in neurodegenerative diseases
    Smolinski, Lukasz
    Czlonkowska, Anna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2016, 50 (06) : 455 - 462
  • [33] Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
    Valera, Elvira
    Masliah, Eliezer
    PHARMACOLOGY & THERAPEUTICS, 2013, 138 (03) : 311 - 322
  • [34] The neuroprotective effects of caffeine in neurodegenerative diseases
    Kolahdouzan, Mahshad
    Hamadeh, Mazen J.
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (04) : 272 - 290
  • [35] Catalpol: A Potential Therapeutic for Neurodegenerative Diseases
    Jiang, B.
    Shen, R. F.
    Bi, J.
    Tian, X. S.
    Hinchliffe, T.
    Xia, Y.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (10) : 1278 - 1291
  • [36] Sirtuins as Possible Targets in Neurodegenerative Diseases
    Donmez, Gizem
    CURRENT DRUG TARGETS, 2013, 14 (06) : 644 - 647
  • [37] Association Between Autophagy and Neurodegenerative Diseases
    Fujikake, Nobuhiro
    Shin, Minkyoung
    Shimizu, Shigeomi
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [38] The Role of Inflammasomes in the Pathogenesis of Neurodegenerative Diseases
    Shevchuk, D., V
    Abramova, A. A.
    Zakharova, M. N.
    NEUROCHEMICAL JOURNAL, 2022, 16 (03) : 271 - 282
  • [39] Towards Unveiling the Genetics of Neurodegenerative Diseases
    Lill, Christina M.
    Bertram, Lars
    SEMINARS IN NEUROLOGY, 2011, 31 (05) : 531 - 541
  • [40] Mitochondrial Dysfunction in Neurodegenerative Diseases and Cancer
    de Moura, Michelle Barbi
    dos Santos, Lucas Santana
    Van Houten, Bennett
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2010, 51 (05) : 391 - 405
12345